Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT03698552 |
| Recruiting Status | Terminated |
| Condition | B-cell Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 57 participants |
| Active Locations | 2 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | December 12, 2025 (Dec 12, 2025) |
As of March 2, 2026: Clinical trial NCT03698552 is currently terminated participants. This clinical trial study for b-cell acute lymphoblastic leukemia is not currently accepting new participants at 2 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03698552 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03698552 was last updated Dec 12, 2025 (December 12, 2025). HelloStudys verifies this status automatically.